Marc Duey is a director of Aprea Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Aug 23 | APRE Aprea Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 500 | 0.00 | 208,878 |
23 Aug 23 | APRE Aprea Therapeutics | Stock Options Common Stock | Grant | Acquire A | No | No | 3.65 | 2,000 | 7.30 k | 2,000 |
23 Aug 22 | APRE Aprea Therapeutics | Common Stock | Conversion | Acquire C | Yes | No | 0 | 11,610 | 0.00 | 602 |
23 Aug 22 | APRE Aprea Therapeutics | Common Stock | Conversion | Acquire C | No | No | 0 | 4,009,690 | 0.00 | 4,167,589 |
23 Aug 22 | APRE Aprea Therapeutics | Series A Non-Voting Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 1,161 | 0.00 | 0 |
23 Aug 22 | APRE Aprea Therapeutics | Series A Non-Voting Convertible Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 400,969 | 0.00 | 0 |